BridgeBio Oncology Therapeutics growth metrics data for the quarter ended Jun 2026. These growth metrics cover 6 quarters of results from Mar 2025 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Growth Metrics | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|
| Growth Ratios | ||||||
| Return on Assets [ROA] Growth (1y)ROA Growth (1y) | -1170.00 | -763.00 | -638.00 | |||
| Return on Assets [ROA] (QoQ)ROA (QoQ) | -1221.00 | -1282.00 | 912.00 | 421.00 | -814.00 | -1157.00 |
| Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) | -748.00 | -693.00 | -870.00 | |||
| Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) | -1009.00 | -1248.00 | 818.00 | 691.00 | -954.00 | -1425.00 |